A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
Journal of Cystic Fibrosis2020Vol. 19(3), pp. 355–358
Citations Over TimeTop 1% of 2020 papers
Rebecca Cosgriff, Susannah Ahern, Scott C. Bell, K. Brownlee, Pierre‐Régis Burgel, Catherine A. Byrnes, Harriet Corvol, Stephanie Y. Cheng, Alexander Elbert, Albert Faro, Christopher H. Goss, Vincent Gulmans, Bruce C. Marshall, Edward F. McKone, Peter G. Middleton, Rasa Ruseckaite, Anne L. Stephenson, S.B. Carr, David W. Reid, Peter Wark, Géraldine Daneau, V. Boussaud, Graziella Brinchault, Emmanuelle Coirier-Duet, J.‐C. Dubus, Dominique Grenet, Sandra de Miranda, L. Beaumont, Reem Kanaan, Muriel Lauraens, Clémence Martin, Marie Mittaine, Anne Prévötat, Martine Reynaud‐Gaubert, Isabelle Sermet‐Gaudelus, Aurélie Tatopoulos, Lutz Nährlich, Barry J. Plant, Cedric Gunaratnam, Abaigeal Jackson, Karin M. de Winter-de Groot, Bart Luijk, Geertjan Wesseling, Mark I. Allenby, J. Duckers, E. Gunn, Andrew Jones, R.I. Ketchell, Susan Madge, Anirban Maitra, Ghulam Mujtaba, Helen Rodgers, Nadia Shafi, Nicholas J. Simmonds, Kevin W Southern, Danie Watson, Samar Rizvi, J Seguin, J. Garbarz, Kristen Rosamilia, Maria Berdella, Jerry A. Nick, R. Belkin, Diana Gilmore, Kim McBennett, Rita Padoan, Marco Salvatore
Abstract
This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.